The revenue target for the fiscal year ending March 2027 was significantly revised downward from 100 billion yen to 85 billion yen, and operating income from 12 billion yen to 3.3 billion yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6737","jir_company_name":"EIZO Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-03-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/6737-20260312-01.pdf","jir_short_summary":"The revenue target for the fiscal year ending March 2027 was significantly revised downward from 100 billion yen to 85 billion yen, and operating income from 12 billion yen to 3.3 billion yen.","jir_summary":"### Overview of Numerical Target Revision\nEIZO Corporation has revised its numerical targets for the fiscal year ending March 2027 (the final year of the 8th Medium-Term Management Plan), significantly lowering revenue from 100 billion yen to 85 billion yen and operating income from 12 billion yen to 3.3 billion yen. Operating margin is expected to decline from 12.0% to 3.9%, and ROE from 8.0% to 3.1%. This is due to prolonged sluggishness in the key European market, deterioration in hospital management in Japan, and rising geopolitical risks.\n\n### Background of the Revision and Future Policy\nAssuming no sharp recovery in the European market, the B&P and Creative Work markets are expected to remain flat. The V&S market is anticipated to grow due to solid demand, while the healthcare market is expected to continue sluggish demand in Japan but recover overseas. Efforts will be made to control costs, keeping fixed costs at the level of the fiscal year ending March 2026. The fiscal year ending March 2027 is positioned as the 'year of recovery of earning power,' and a roadmap aiming for sustained ROE improvement will be presented in the next medium-term management plan starting from the fiscal year ending March 2028.","jir_financial_highlights":"Net Sales: 85 billion yen (150 billion yen below initial plan)\nOperating Income: 3.3 billion yen (8.7 billion yen below initial plan)\nOperating Margin: 3.9% (8.1 points below initial plan)\nROE: 3.1% (4.9 points below initial plan)","jir_category":"","jir_hashtags":"#EIZOCorporation, #MediumTermManagementPlanRevision, #JapaneseStocks","jir_key_figures":"Net Sales: 85 billion yen (150 billion yen below initial plan)\nOperating Income: 3.3 billion yen (8.7 billion yen below initial plan)\nROE: 3.1% (4.9 points below initial plan)","jir_meta_title":"EIZO Corporation Revises Down Medium-Term Management Plan Targets to 85 Billion Yen Revenue and 3.3 Billion Yen Operating Income for Fiscal 2027","jir_meta_description":"EIZO Corporation has revised downward its numerical targets in the medium-term management plan for fiscal 2027 to 85 billion yen in revenue and 3.3 billion yen in operating income, citing sluggish European markets and deteriorating hospital management in Japan.","jir_og_title":"EIZO Corporation Significantly Revises Numerical Targets in Medium-Term Management Plan","jir_og_description":"Significant downward revision of revenue and operating income targets for fiscal 2027. Focus on rebuilding the earnings base and aiming for ROE improvement in the next plan.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9640,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-34424","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n